Life Sciences 360
Life Sciences 360 is an interview show that educates anyone on challenges, trends, and insights in the life-sciences industry. Hosted by Harsh Thakkar, a life-sciences industry veteran and CEO and co-founder of Qualtivate, the show features subject-matter experts, business leaders, and key life-science partners contributing to bringing new therapies to patients worldwide. Harsh is passionate about advancements in life sciences and tech and is always eager to learn from his guests— making the show both informative and useful.
Episodes
81 episodes
Pandora's Box of Secrets EXPOSED in Drug Pricing Transparency!
The Hidden Math Behind Drug Pricing: Why Patients Pay More Than They ShouldIn this episode, Michael Grosberg, VP of Product Management at Model N, breaks down the complex drug pricing ecosystem—revealing how rebates, PBMs, and outdated ...
•
Season 3
•
Episode 81
•
30:15
A CCO’s Brutally Honest Advice if You Want to Succeed in Pharma Commercialization
Early Commercialization Strategies That Actually Work (Especially for Startups!) In this episode, John Harlow, Chief Commercial Officer at Melinta Therapeutics, shares real-world strategies for how lean pharma startups can win the commercializa...
•
Season 3
•
Episode 80
•
31:45
Digital Health Expert: THIS is the No.1 Roadblock to Healthcare AI Adoption
Healthcare AI adoption is transforming the way we address risk, confidentiality, and patient care. In this episode, RJ Kedziora, co-founder of Estenda Solutions talks about the practical steps to safely integrate AI in clinical workflows. <...
•
Season 3
•
Episode 79
•
35:12
Tired of Supply Chain Errors? Here’s the Fix: Drug Serialization for DSCSA Compliance
Drug serialization is at the heart of modern pharmaceutical supply chain security. In this episode Michael Rowe, Senior Director of DSCSA and Serialization Services at TwoLabs, talks about the critical role of drug serialization and DSCSA...
•
Season 3
•
Episode 78
•
39:50
Why Equitable Healthcare is the KEY to Better Health
Equitable healthcare is the key to bridging health gaps and creating better patient outcomes. In this episode, Amy West, Principal, Advisory Services at HitLab, share her insights on how technology, digital health, and data can reshape access t...
•
Season 3
•
Episode 77
•
22:03
Can AI Help Doctors Find Cancer Faster?
Have you ever wondered if AI could help doctors find cancer faster and more accurately? In this episode, we explore OmniScreen, an AI-powered biomarker tool that is revolutionizing cancer diagnostics.Joe Oakley, a pathologist and expert ...
•
Season 3
•
Episode 76
•
36:55
Why Science Marketing Will Make Your Company EXPLODE in 2025?
Have you ever wondered why marketing in the life sciences industry is so different from traditional marketing? In this episode, we dive deep into the power of science marketing, the impact of brand storytelling, and how companies can successful...
•
Season 3
•
Episode 75
•
44:05
Why Most New Drugs Don't Launch: The Hidden Challenges in Pharma
Have you ever wondered why so many new drugs fail even after years of research and billions in investment? In this episode, we dive deep into the challenges of drug commercialization, the role of AI in pharma, and the biggest mistakes companies...
•
Season 3
•
Episode 74
•
37:44
Why 55% of Clinical Trials Fail – The Truth About Drug Development
Have you ever wondered why so many clinical trials fail before reaching the market? In this episode, we dive deep into the hidden challenges of clinical trials with Rob Freishtat, President and Co-Founder of Uncommon Cures and a professor at Ge...
•
Season 3
•
Episode 73
•
43:51
How to Get Quick Access to GLP-1 Medications without Health Insurance ft. Dr. Jonathan Kaplan
In this episode of Life Sciences 360, we dive deep into the world of GLP-1 medications with Dr. Jonathan Kaplan. We discuss weight management, how these medications work, their impact beyond weight loss, and the ethical considerations surroundi...
•
Episode 72
•
41:10
Astellas Pharma’s Approach to Cell and Gene Therapy
In this episode of LifeSciences 360, we dive into the fascinating world of cell and gene therapy manufacturing with Carlos Yuraszeck. With over 16 years of experience, Carlos shares his deep insights into the unique challenges, opportunities, a...
•
Episode 71
•
36:11
ISPE’s Role in Shaping the Future of mRNA and Personalized Medicine
In this episode of Life Sciences 360, we dive into the evolution of pharmaceutical and biotech manufacturing with our guest, Scott, a seasoned expert with nearly 30 years of experience working with industry giants like Novartis, Biogen, Thermo ...
•
Episode 70
•
34:03
Balancing Leadership Roles in a High-Stakes Industry with Taggart McGurrin
Welcome to another episode of Life Sciences 360! Today, we're diving into the intricate world of life sciences leadership with a special guest who's worn nearly every hat in the industry—Taggart McGurrin. Starting in finance, transitioning to l...
•
Episode 69
•
30:00
Why Antimicrobial Resistance Is the Biggest Challenge in Public Health
In this episode of Life Sciences 360, host Harsh Thakkar sits down with Marc Sheetz, Associate Dean of Research at Midwestern University's College of Pharmacy, to discuss the growing concern of antimicrobial resistance and the field of pharmaco...
•
Episode 68
•
41:08
The Secret to Better Medications: Standardizing Pharmacogenomics (PGx) Testing
Imagine knowing how your body will respond to a medication before you even take it! In this episode, Harsh Thakkar interviews Sarah Rogers, co-founder and president of the American Society of Pharmacovigilance (ASP) and an Assistant Professor a...
•
Episode 67
•
29:59
Life Sciences Marketing Agency CEO on How to Combine Storytelling and Science for Impact
In this episode, Harsh Thakkar welcomes David Ormesher, CEO of CG Life, a leading marketing agency in the life sciences and pharmaceutical sectors. David shares over 30 years of experience in life science marketing and storytelling. From startu...
•
Episode 66
•
36:46
Could Worms REALLY Be the Key to Curing Autoimmune Diseases?
In this episode, we dive deep into a fascinating topic worm-derived therapeutics with our special guest Andrea, the founder and CEO of Holoclara. Did you know that autoimmune and allergic diseases were rare before the 1900s? What changed? Andre...
•
Episode 65
•
29:08
How Amprion’s Test is Changing ALS, Dementia, and Parkinson’s Disease Diagnosis
Learn how misfolded proteins trigger cascading effects in the brain, leading to these devastating conditions, and how early detection can change the trajectory of treatment. Whether you’re curious about ALS, Parkinson’s, Dementia, or the role o...
•
Episode 64
•
37:18
How Generative AI Finds Cures for Rare Diseases Faster
Welcome to episode 063 of Life Sciences 360.We dive deep into the groundbreaking role of AI in healthcare and life sciences with Shweta from Google Cloud. Learn how AI is accelerating drug discovery, enhancing patient care, and revo...
•
Episode 63
•
37:57
3 Steps to Avoid Burnout and Thrive in Biopharma, from a Global Expert
Welcome to episode 062 of Life Sciences 360.In this episode, we dive into an engaging conversation with Tom, a seasoned consultant, on how to recognize the early signs of burnout, foster a healthy and innovative work environment, and im...
•
Episode 62
•
35:57
How Samsung Biologics Achieved 16 Top Pharma Partnerships as a CDMO
Welcome to episode 061 of Life Sciences 360.In this episode of Life Sciences 360, host Harsh Thakkar sits down with Kevin Sharp, Senior Vice President and Head of Global Sales at Samsung Biologics. They dive deep into the evolving CDMO ...
•
Episode 61
•
43:15
Why the Top 1% are lonely- insights from Dr. Robyn Odegaard
Welcome to episode 060 of Life Sciences 360.In this episode of Life Sciences 360, host Harsh Thakkar sits down with Dr. Robin Odegaard, a high-performance business psychologist and professional confidant, to discuss the hidden struggles...
•
Episode 60
•
36:17
The Science Behind Tome’s Programmable Genomic Integration Technology with CSO John Finn
Welcome to episode 059 of Life Sciences 360.In this episode of Life Sciences 360, Harsh Thakkar is joined by John Finn, Chief Scientific Officer at Tome Biosciences. John shares his inspiring journey of overcoming challenges, like his s...
•
Episode 59
•
43:30
Inside the Lab: How Singota Solutions Leads in Early-Stage Pharma Development
Welcome to episode 058 of Life Sciences 360.In this insightful episode of Life Sciences 360, hosted by Harsh Thakkar, we explore the dynamic world of Contract Development and Manufacturing Organizations (CDMOs) with Ryan Memmer, Manager...
•
Episode 58
•
32:25
Bioidentical Hormone Replacement: A Deep Dive with Dr. Greg Brannon
Welcome to episode 057 of Life Sciences 360.In this special episode of Life Sciences 360, hosted by Harsh Thakkar, we dive into the fascinating world of bioidentical hormone replacement therapy (BHRT) with Dr. Greg Brannon, Medical Dire...
•
Episode 57
•
38:19